Amdocs (NASDAQ:DOX – Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a report issued on Saturday.
Several other research firms have also recently commented on DOX. Stifel Nicolaus lowered their target price on shares of Amdocs from $97.00 to $88.00 and set a “buy” rating for the company in a research note on Wednesday, February 4th. Barclays reduced their target price on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating on the stock in a report on Wednesday, February 4th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Amdocs in a research report on Tuesday, January 27th. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $92.33.
Get Our Latest Report on Amdocs
Amdocs Stock Up 0.8%
Amdocs (NASDAQ:DOX – Get Free Report) last posted its quarterly earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share for the quarter, topping analysts’ consensus estimates of $1.75 by $0.06. The business had revenue of $1.16 billion for the quarter, compared to analysts’ expectations of $1.15 billion. Amdocs had a net margin of 12.47% and a return on equity of 20.19%. The business’s revenue for the quarter was up 4.1% on a year-over-year basis. During the same period in the prior year, the company posted $1.66 EPS. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. As a group, analysts expect that Amdocs will post 6.21 EPS for the current year.
Hedge Funds Weigh In On Amdocs
Large investors have recently made changes to their positions in the business. Pzena Investment Management LLC grew its holdings in shares of Amdocs by 82.6% in the 4th quarter. Pzena Investment Management LLC now owns 12,037,015 shares of the technology company’s stock worth $969,100,000 after acquiring an additional 5,443,766 shares during the last quarter. LSV Asset Management lifted its position in Amdocs by 0.8% in the 4th quarter. LSV Asset Management now owns 3,678,532 shares of the technology company’s stock worth $296,159,000 after buying an additional 29,829 shares in the last quarter. Allspring Global Investments Holdings LLC boosted its position in Amdocs by 1.8% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 3,165,988 shares of the technology company’s stock valued at $253,786,000 after purchasing an additional 54,676 shares during the last quarter. Wellington Management Group LLP grew its stake in shares of Amdocs by 3.0% in the 3rd quarter. Wellington Management Group LLP now owns 3,151,532 shares of the technology company’s stock valued at $258,583,000 after buying an additional 91,900 shares in the last quarter. Finally, Vanguard Group Inc. grew its position in Amdocs by 0.3% in the third quarter. Vanguard Group Inc. now owns 3,066,444 shares of the technology company’s stock worth $251,602,000 after acquiring an additional 9,207 shares in the last quarter. Institutional investors own 92.02% of the company’s stock.
Amdocs Company Profile
Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.
Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.
See Also
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
